30. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
09.11. - 10.11.2023, Köln
Abstracts
Meeting Abstract
(23gaa01)
[Volltext]
Pharmacological and non-pharmacological treatment of sleep disorders in the hospital
Aldudak Tursun C, Thürmann P, Schmiedl S[Volltext]
Meeting Abstract
(23gaa02)
[Volltext]
Scientific application of the web-based health portal VITERIO for the acquisition and analysis of digital outcome parameters
Bachmeier B, Melchart D[Volltext]
Meeting Abstract
(23gaa03)
[Volltext]
Synthesizing evidence-based recommendations for tapering psychotropic, sedative, and anticholinergic medications: A rapid review
Bernartz K, Claaßen S, Chapidi K, Chapidi P, Picker-Huchzermeyer S, Nolte H, Dreischulte T, Härdtlein A, Brisnik V, Mortsiefer A, Peter S, Maas M, Seidling H, Klasing S, Horowitz M, Muth C, Puzhko S[Volltext]
Meeting Abstract
(23gaa04)
[Volltext]
Controversy from pharmacovigilance of acetylsalicylic acid as a suspect causative agent for appearance and disappearance of Reye’ Syndrome in children
Bernd A, Möser EM, Vogel D, Wofram K, Ivonchyk O, Heuer H[Volltext]
Meeting Abstract
(23gaa05)
[Volltext]
Safety first? Drug-related problems at admission to surgery: A retrospective study
Clemens S, Simon C, Kanduth K, Rose O[Volltext]
Meeting Abstract
(23gaa06)
[Volltext]
Real-world evidence on the use of herbal medicines in gynecological complaints
Drebka A, Ochs T, Raskopf E, Shah-Hosseini K, Mösgens R, Bachmeier B[Volltext]
Meeting Abstract
(23gaa07)
[Volltext]
Analysis of adverse drug reaction reports related to fluoroquinolones between 2014–2019 and 2020–2022
Dubrall D, Wicherski J, Schmid M, Haenisch B, Sachs B[Volltext]
Meeting Abstract
(23gaa08)
[Volltext]
Results and experiences of the ARMIN model project (“Arzneimittelinitiative Sachsen-Thueringen”)
Fuchs A[Volltext]
Meeting Abstract
(23gaa09)
[Volltext]
Results and learnings of the project to improve the transparency of medicaction process in nursing homes (“Arzneimitteltransparenz im Pflegeheim”)
Fuchs A[Volltext]
Meeting Abstract
(23gaa10)
[Volltext]
Do privately insured patients receive new antidiabetic drugs earlier than patients insured under the statutory health insurance scheme? The case of glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors
Grimmsmann T, Kostev K, Himmel W[Volltext]
Meeting Abstract
(23gaa11)
[Volltext]
Differences in psychopharmacological outpatient treatment between suicidal adolescents suffering from adjustment disorders and major depressive disorders
Hach I, Bertsch T, Nonell P[Volltext]
Meeting Abstract
(23gaa12)
[Volltext]
A geriatric pharmacist’s contribution to nurses’ education on medication – medication in care planning
Hagedorn M[Volltext]
Meeting Abstract
(23gaa13)
[Volltext]
Antibiotic use in patients with urinary tract infections: Prescription trends from 2015 to 2019
Jobski K, Schmiemann G, Hamprecht A, Hoffmann F[Volltext]
Meeting Abstract
(23gaa14)
[Volltext]
Introduction of a unit-dose supply in the context of closed-loop medication management at a clinic of the University Hospital Jena (UKJ) – acceptance and feasibility from the ward staff point of view
Kessler C, Meissner F, Iffland A, Hartmann M, Bleidorn J, Farker K[Volltext]
Meeting Abstract
(23gaa15)
[Volltext]
Pain therapy in patients without a diagnosis of malignant neoplasm: Frequency of non-opioids and opioids prescribing and observed drug therapy safety risks
Lappe V, Schubert I, Grandt D[Volltext]
Meeting Abstract
(23gaa16)
[Volltext]
Multiple sclerosis: Detecting adverse effects with routine practice data
Marx C, Basoglu A, Berger K, Drechsel-Bäuerle U, Keller-Stanislawski B, Kexel E, Kraft K, Stahmann A, Below M[Volltext]
Meeting Abstract
(23gaa17)
[Volltext]
Assessing the relevance of drug-related problems and pharmaceutical interventions in the interprofessional medication management programme ARMIN
Müller U, Eickhoff C, Petersen M, Strunz AK, Ruschkowski M, Schulz M[Volltext]
Meeting Abstract
(23gaa18)
[Volltext]
Development of a qualitative online survey on need, request, acceptance, benefits, and accessibility of herbal medicines for the treatment of gynaecological complaints
Ochs T, Bößneck N, Jalil B, Heinrich M, Bachmeier B[Volltext]
Meeting Abstract
(23gaa19)
[Volltext]
How do sex and gender influence chronic pain therapy? – Analysis of existing literature for the GESCO-Study Sex- and gender-sensitive primary care intervention for patients with chronic non-cancer pain (CNCP) receiving long-term opioid therapy (LTOT))
Preuß J, Bencheva V, Mortsiefer A, Schmidt A, Pitrowski A, Weckbecker K, Kufeld N, Just J, Wiese B, Kersting C, Thürmann P[Volltext]
Meeting Abstract
(23gaa20)
[Volltext]
Medical drug expertise assessments in the Quality Assurance in the Medical Advisory Service Institutions in Germany
Ries V, Schuster R, Menz PU, Burmester M[Volltext]
Meeting Abstract
(23gaa21)
[Volltext]
Polypharmacy in older multimorbid patients: Agreement between GP-reported and patient-reported drugs
Schäfer L, Paulitsch M, Hanf M, Dinh TS, Klein AA, Klasing S, Seidling HM, Voigt K, van den Akker M[Volltext]
Meeting Abstract
(23gaa22)
[Volltext]
Prevalence and time trends of potentially drug-related hospital admissions
Schechner M, Weglage C, Rottenkolber M, Dreischulte T[Volltext]
Meeting Abstract
(23gaa23)
[Volltext]
Prescribing of opioid analgesics in Germany: Opposite trends when different quantification measures are used
Scholle O, Jobski K, Viebrock J, Haug U[Volltext]
Meeting Abstract
(23gaa24)
[Volltext]
Consistency of recommendations for pharmacological treatment of predisposing conditions as an essential component of primary cardiovascular disease prevention in general practice: Findings from a systematic guideline review
Schürmann L, Bredehorst M, González-González AI, Muth C, Van der Wardt V, Haasenritter J, Puzhko S[Volltext]
Meeting Abstract
(23gaa25)
[Volltext]
Antibiotic prescriptions before, during and after the corona pandemic in Schleswig-Holstein
Schuster R, Emcke T, von Arnstedt E, Ries V, Burmester M[Volltext]
Meeting Abstract
(23gaa26)
[Volltext]
Potential life-threatening adverse drug reactions of fluoroquinolones – a pharmacoepidemiological analysis in German health claims data
Wicherski J, Peltner J, Astvatsatourov A, Becker C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern W, Weltermann B, Haenisch B[Volltext]
Meeting Abstract
(23gaa27)
[Volltext]
Gender differences in drug prescribing by disease group
Zawinell A, Niepraschk-von Dollen K[Volltext]
